Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype
Author:
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-019-05324-7.pdf
Reference47 articles.
1. Hatzis C, Symmans WF, Zhang Y et al (2016) Relationship between complete pathologic response to neoadjuvant chemotherapy and survival in triple-negative breast cancer. Clin Cancer Res 22:26–33
2. Bianchini G, Balko JM, Mayer IA et al (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13:674–690. https://doi.org/10.1038/nrclinonc.2016.66
3. Yam C, Mani SA, Moulder SL (2017) Targeting the molecular subtypes of triple negative breast cancer: understanding the diversity to progress the field. Oncologist 22:1086–1093. https://doi.org/10.1634/theoncologist.2017-0095
4. ClinicalTrials.gov. https://clinicaltrials.gov/
5. Lehmann BD, Bauer JA, Chen X et al (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Investig 121:2750–2767. https://doi.org/10.1172/JCI45014
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bioelectric pharmacology of cancer: A systematic review of ion channel drugs affecting the cancer phenotype;Progress in Biophysics and Molecular Biology;2024-09
2. TRP channels as molecular targets to relieve endocrine-related diseases;TRP Channels as Therapeutic Targets;2024
3. Biological Effects of Modifications of the Englerin A Glycolate;ACS Medicinal Chemistry Letters;2022-08-22
4. TRP Channels as Molecular Targets to Relieve Endocrine-Related Diseases;Frontiers in Molecular Biosciences;2022-04-28
5. An ex vivo perfused ventilated murine lung model suggests lack of acute pulmonary toxicity of the potential novel anticancer agent (−)-englerin A;Archives of Toxicology;2022-02-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3